TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS

We had reported earlier(1) on a novel series of potent and selective t etrapeptide cholecystokinin-A (CCK-A) agonists of the general structur e Boc-Trp-Lys[epsilon-Y]-Asp-N(R)PheNH(2) [Y = amides, ureas; R = H, M e] that were potent anorectic agents in rats. In an effort to optimize the potency, selectivity, stability, and efficacy of our lead candida te A-71623 [R = Me, Y = o-tolylaminocarbonyl; Tac] toward-development of a clinical candidate; we have explored a series of analogues in whi ch the N-terminal Boc functionality was systematically replaced with v arious amides, ureas, carbamates, and sulfonamides of differing size, hydrophobicity; and stereoelectronic properties. In;general, these ana logues maintained good potency and selectivity for the CCK-A receptor (guinea pig pancreas), as well as potent anorectic activity in rats. T hose analogues exhibiting equal or superior activity compared to A-716 23 but differing physicochemical properties may represent superior dru g candidates.